FDA Ignored Device Reclassification Process, DC Circ. Told
ReGen Biologics Inc. urged a D.C. Circuit panel on Tuesday to nix a U.S. Food and Drug Administration decision reclassifying its knee implant device as not being substantially similar to others...To view the full article, register now.
Already a subscriber? Click here to view full article